Guillaume Robert

7.4k total citations · 1 hit paper
135 papers, 4.0k citations indexed

About

Guillaume Robert is a scholar working on Molecular Biology, Cognitive Neuroscience and Neurology. According to data from OpenAlex, Guillaume Robert has authored 135 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Cognitive Neuroscience and 22 papers in Neurology. Recurrent topics in Guillaume Robert's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (19 papers) and Functional Brain Connectivity Studies (18 papers). Guillaume Robert is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (19 papers) and Functional Brain Connectivity Studies (18 papers). Guillaume Robert collaborates with scholars based in France, United States and Switzerland. Guillaume Robert's co-authors include Patrick Auberger, Alexandre Puissant, Frédéric Luciano, Arnaud Jacquel, Dominique Drapier, Sophie Raynaud, Frédéric Bost, Jill‐Patrice Cassuto, Nina Fenouille and Marc Vérin and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Guillaume Robert

124 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1

2011 526 citations Claire Regazzetti, Guillaume Robert et al. Cancer Research profile →

Peers

Countries citing papers authored by Guillaume Robert

Since Specialization

Citations

This map shows the geographic impact of Guillaume Robert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume Robert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume Robert more than expected).

Fields of papers citing papers by Guillaume Robert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillaume Robert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume Robert. The network helps show where Guillaume Robert may publish in the future.

Co-authorship network of co-authors of Guillaume Robert

This figure shows the co-authorship network connecting the top 25 collaborators of Guillaume Robert. A scholar is included among the top collaborators of Guillaume Robert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillaume Robert. Guillaume Robert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Measuring the clinical dimensions of negative symptoms through the Positive and Negative Syndrome Scale 2025 ·DR-NTU (Nanyang Technological University) ·Noham Wolpe, Andrea Perrottelli, Luigi Giuliani, (unknown), Gurpreet Rekhi, Peter B. Jones, Miquel Bernardo, María Paz García‐Portilla, Stefan Kaiser, Guillaume Robert, Philippe Robert, Anna Mané, Silvana Galderisi, Jimmy Lee, Armida Mucci, Emilio Fernández-Egea	0
2	Inflammatory and MRI perfusion biomarkers in predicting persistence of depression: a 6-month Longitudinal Study 2025 ·Translational Psychiatry ·Jean-Marie Batail, Isabelle Corouge, (unknown), (unknown), Guillaume Robert, Dominique Drapier	0
3	Impact of clean intermittent self-catheterization and indwelling catheterization on perioperative outcomes in patients with urinary retention undergoing BPH surgery: A comparative monocentric retrospective study 2024 ·PubMed ·(unknown), Carsten Klein, (unknown), (unknown), (unknown), V. Estrade, (unknown), Franck Bladou, Guillaume Robert	0
4	HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma 2024 ·Cell Death Discovery ·Julie Contenti, Yongjian Guo, Magalie Larcher, (unknown), Matthieu Rouleau, Marie Irondelle, (unknown), (unknown), (unknown), Florence Pédeutour, Issam Ben‐Sahra, (unknown), (unknown), Luca Tiberi, Guillaume Robert, Célio Pouponnot, Frédéric Bost, Nathalie M. Mazure	2
5	A descriptive study of first time outpatient public psychiatric care after 65 years 2024 ·BMC Health Services Research ·(unknown), (unknown), (unknown), Dominique Somme, Guillaume Robert	0
6	Quantifying Apathy in Late-Life Depression: Unraveling Neurobehavioral Links Through Daily Activity Patterns and Brain Connectivity Analysis 2024 ·Biological Psychiatry Cognitive Neuroscience and Neuroimaging ·(unknown), (unknown), Thomas Desmidt, (unknown), (unknown), (unknown), Élise Bannier, Laurent Barantin, Dominique Drapier, Jean-Marie Batail, Renaud David, (unknown), Guillaume Robert	1
7	The generation, activation, and polarization of monocyte-derived macrophages in human malignancies 2023 ·Frontiers in Immunology ·Paul Chaintreuil, (unknown), (unknown), (unknown), (unknown), Guillaume Robert, Arnaud Jacquel, Patrick Auberger	44
8	Deoxygenative Intramolecular Minisci‐Type Reaction to Access Fused Heterocyclic Scaffolds 2022 ·European Journal of Organic Chemistry ·Francisco José Aguilar Troyano, (unknown), Fabian Mohr, Guillaume Robert, Adrián Gómez‐Suárez	4
9	Tolerability of duloxetine in elderly and in non-elderly adults: a protocol of a systematic review and individual participant data meta-analysis of randomized placebo-controlled trials 2022 ·Systematic Reviews ·(unknown), Chloé Rousseau, (unknown), Florian Naudet, Guillaume Robert	2
10	Functional Role of the Cerebellum in Parkinson Disease 2021 ·Neurology ·(unknown), Jean‐François Houvenaghel, Thibaut Dondaine, Sophie Drapier, Paul Sauleau, Dominique Drapier, Joan Duprez, (unknown), Florence Le Jeune, Marc Vérin, Guillaume Robert	25
11	Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort 2019 ·Neurobiology of Aging ·Thomas Desmidt, Julien Delrieu, Thibaud Lebouvier, Guillaume Robert, Renaud David, (unknown), Alexandre Surget, Catherine Belzung, Nicolas Arlicot, Maria-João Ribeiro, Pierre Payoux, Bruno Vellas, Wissam El‐Hage, Elsa Tavernier, Vincent Camus	13
12	An miRNA–DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia 2016 ·Clinical Cancer Research ·(unknown), Catherine Koering, (unknown), Delphine Maucort‐Boulch, Guillaume Robert, Patrick Auberger, Pascale Flandrin‐Gresta, Lionel Adès, Pierre Fenaux, Olivier Kosmider, Emmanuelle Tavernier, Jérôme Cornillon, Denis Guyotat, Lydia Campos, Franck Mortreux, Eric Wattel	29
13	Impulsive oculomotor action selection in Parkinson’s disease 2016 ·Neuropsychologia ·Joan Duprez, Jean‐François Houvenaghel, (unknown), Florian Naudet, Guillaume Robert, Dominique Drapier, Marc Vérin, Paul Sauleau	14
14	The caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS production 2012 ·Cell Death and Differentiation ·Guillaume Robert, Alexandre Puissant, Maeva Dufies, Sandrine Marchetti, Arnaud Jacquel, Thomas Cluzeau, Pascal Colosetti, Nathalie Belhacène, Philipp J. Kahle, Cristine Alvès da Costa, Frédéric Luciano, Frédéric Checler, Patrick Auberger	20
15	Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1 breakdown → 2011 ·Cancer Research ·(unknown), Claire Regazzetti, Guillaume Robert, Kathiane Laurent, Y. Le Marchand‐Brustel, Patrick Auberger, Jean‐François Tanti, Sophie Giorgetti‐Peraldi, Frédéric Bost	526
16	Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC 2010 ·Cancer Research ·Nina Fenouille, Alexandre Puissant, Maeva Dufies, Guillaume Robert, Arnaud Jacquel, Mickaël Ohanna, Marcel Deckert, Jean‐Max Pasquet, François‐Xavier Mahon, Jill‐Patrice Cassuto, Sophie Raynaud, Sophie Tartare‐Deckert, Patrick Auberger	52
17	Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation 2010 ·Cancer Research ·Alexandre Puissant, Guillaume Robert, Nina Fenouille, Frédéric Luciano, Jill‐Patrice Cassuto, Sophie Raynaud, Patrick Auberger	323
18	Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest 2009 ·Cancer Research ·(unknown), Nina Fenouille, Patricia Abbe, Guillaume Robert, Stéphane Rocchi, (unknown), Christophe Denoyelle, Michel Ticchioni, Jean‐Paul Ortonne, Robert Ballotti, Marcel Deckert, Sophie Tartare‐Deckert	66
19	SPARC Represses E-Cadherin and Induces Mesenchymal Transition during Melanoma Development 2006 ·Cancer Research ·Guillaume Robert, Cédric Gaggioli, (unknown), Carine Chavey, Patricia Abbe, Édith Aberdam, (unknown), Amparo Cano, Antonio Garcı́a de Herreros, Robert Ballotti, Sophie Tartare‐Deckert	134
20	Implementability of Message Sequence Charts 1998 ·Ferhat Khendek, Guillaume Robert, (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact